RETINOIC ACID RECEPTOR GAMMA AGONISTS TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY

• 收藏
• 分享

专利权人:

Northwestern University

发明人:

Paul W. Burridge

申请号：

US16376392

公开号：

US20190358250A1

申请日:

2019.04.05

申请国别(地区):

US

年份:

2019

代理人:

摘要：

Disclosed are methods, pharmaceutical compositions, kits, and systems for treating or preventing cardiotoxicity in a subject undergoing treatment with an anthracycline chemotherapeutic agent. The methods, pharmaceutical compositions, kits, and systems typically include or utilize an agonist of the retinoic acid receptor gamma (RARG).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/